| 000 | 01794 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513184434.0 | ||
| 264 | 0 | _c19990625 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/s0024-3205(99)00164-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZakaroff-Girard, A | |
| 245 | 0 | 0 |
_aThe priming effect of 12(S)-hydroxyeicosatetraenoic acid on lymphocyte phospholipase D involves specific binding sites. _h[electronic resource] |
| 260 |
_bLife sciences _c1999 |
||
| 300 |
_a2135-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a12-Hydroxy-5,8,10,14-eicosatetraenoic Acid _xmetabolism |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aConcanavalin A _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFatty Acids _xmetabolism |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xcytology |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 | _aPertussis Toxin |
| 650 | 0 | 4 |
_aPhospholipase D _xmetabolism |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPhosphotyrosine _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSuramin _xpharmacology |
| 650 | 0 | 4 | _aTritium |
| 650 | 0 | 4 |
_aVirulence Factors, Bordetella _xpharmacology |
| 700 | 1 | _aDubois, M | |
| 700 | 1 | _aGilbert, M | |
| 700 | 1 | _aMeskini, N | |
| 700 | 1 | _aNémoz, G | |
| 700 | 1 | _aLagarde, M | |
| 700 | 1 | _aPrigent, A F | |
| 773 | 0 |
_tLife sciences _gvol. 64 _gno. 23 _gp. 2135-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0024-3205(99)00164-2 _zAvailable from publisher's website |
| 999 |
_c10331123 _d10331123 |
||